文献速递神经肿瘤

经蝶垂体腺瘤切除术后外科降阶梯方案降低费用的病例系列

Use of a Surgical Stepdown Protocol for Cost Reduction After Transsphenoidal Pituitary Adenoma Resection: A Case Series.
PubMed 文献 · World Neurosurg · 2021-06-16

本研究评估经蝶垂体腺瘤切除术后降阶梯单元方案对费用的影响。降阶梯组总费用降低12.5%(P=0.01),主要来自设施使用费降低8.9%(P=0.02),并发症率无差异。

要点

  • 降阶梯组总费用较全ICU组降低12.5%(P=0.01)。
  • 设施使用费用降低8.9%(P=0.02)是费用下降的主要驱动因素。
  • 降阶梯组与全ICU组并发症率和住院时长无显著差异。

核心结论

  • 术后降阶梯单元可使符合条件的垂体瘤患者费用降低12.5%,且不增加并发症。

主要发现

  • 降阶梯组、ICU组和历史对照组的住院总时长分别为4.8±1.0、5.9±2.8和4.4±4.3天,差异无统计学意义(P=0.1)。
  • 降阶梯组总费用降低12.5%(P=0.01),设施使用费用降低8.9%(P=0.02)。
  • 降阶梯组与全ICU组的并发症率和发病率相似。
  • 外推至历史患者提示2011至2016年间可节省约225,000美元。

关键数值与推荐

  • 降阶梯单元与全ICU的分配依据预设标准,原文未列出具体条款。
  • 历史对照提示超过半数垂体患者符合降阶梯单元准入条件。

临床怎么用

  • 对符合预设标准的经蝶垂体腺瘤切除术后患者,可考虑收入降阶梯单元而非全ICU以降低费用。
  • 降阶梯管理未增加并发症率,可作为术后管理路径的备选方案。

局限性

  • 历史对照比较可能存在时间偏倚。
  • 降阶梯单元准入的预设标准原文未详细报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: No established standard of care currently exists for the postoperative management of patients with surgically resected pituitary adenomas. Our objective was to quantify the efficacy of a postoperative stepdown unit protocol for reducing patient cost. METHODS: In 2018-2020, consecutive patients undergoing transsphenoidal microsurgical resection of sellar lesions were managed postoperatively in the full intensive care unit (ICU) or an ICU-based surgical stepdown unit based on preset criteria. Demographic variables, surgical outcomes, and patient costs were evaluated. RESULTS: Fifty-four patients (27 stepdown, 27 full ICU; no difference in age or sex) were identified. Stepdown patients were also compared with 634 historical control patients. The total hospital length of stay was no different among stepdown, ICU, and historical patients (4.8 ± 1.0 vs. 5.9 ± 2.8 vs. 4.4 ± 4.3 days, respectively, P = 0.1). Overall costs were 12.5% less for stepdown patients (P = 0.01), a difference mainly driven by reduced facility utilization costs of -8.9% (P = 0.02). The morbidity and complication rates were similar in the stepdown and full ICU groups. Extrapolation of findings to historical patients suggested that ∼$225,000 could have been saved from 2011 to 2016. CONCLUSIONS: These results suggest that use of a postoperative stepdown unit could result in a 12.5% savings for eligible patients undergoing treatment of pituitary tumors by shifting patients to a less acute unit without worsened surgical outcomes. Historical controls indicate that over half of all pituitary patients would be eligible. Further refinement of patient selection for less costly perioperative management may reduce cost burden for the health care system and patients.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hunsaker JC, Khan M, Gamblin A, et al. Use of a Surgical Stepdown Protocol for Cost Reduction After Transsphenoidal Pituitary Adenoma Resection: A Case Series. World Neurosurg. 2021. PMID: 34098141. doi:10.1016/j.wneu.2021.05.126

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。